GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (ASX:PER) » Definitions » Short Percentage of Float

Percheron Therapeutics (ASX:PER) Short Percentage of Float


View and export this data going back to 2001. Start your Free Trial

What is Percheron Therapeutics Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Percheron Therapeutics's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, Percheron Therapeutics's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Percheron Therapeutics's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Percheron Therapeutics's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Percheron Therapeutics's Short Percentage of Float falls into.


Percheron Therapeutics (ASX:PER) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (ASX:PER) » Definitions » Short Percentage of Float
Comparable Companies
ASX:LV1 ASX:NXS ASX:MVP ASX:LGP ASX:VIT ASX:IVX ASX:EOF ASX:ECS ASX:CAN ASX:IDT ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA TSE:4507 VTRS NBIX XSWX:SDZ
Traded in Other Exchanges
ATHJF:USA AWY0:Germany
Address
14 Wallace Avenue, Toorak, VIC, AUS, 3142
Website
https://www.antisense.com.au
Antisense Therapeutics Ltd is a drug manufacturer. The company is engaged in research and development of novel antisense pharmaceuticals. The company operates in two segments that have been identified based on its antisense oligonucleotide products as ATL1102 and ATL1103.

Percheron Therapeutics (ASX:PER) Headlines

No Headlines